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Dietary supplements, including those containing botanical ingredients and botanical-derived compounds, have been 
marketed to consumers globally for many decades. However, the legislative framework for such products remains 
inconsistent across jurisdictions internationally. A common problem, concerning these nutraceutical products, is 
deficient  information and lack of data for assessing the hazards posed to human health. The main objective of this 
study is to explore the use of in silico tools in a risk assessment context of nutraceutical  product, to relate properties 
of the molecular structure to the toxic effect of the chemical substance, by using principles and methods of 
computational chemistry. Further consideration of the actual impact of adverse events arising from nutraceutical 
food supplement usage will be helpful in guiding such issue as a potential for misidentification, and adulteration of 
botanical supplements by pharmacologically active substances. 
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Dragon fruit is a tropical fruit belongs to Cactae family of genus Hylocereus. Popularly known as ‘buah Naga’ in 
Malay, Dragon fruit is not only preferred for its unique taste, but this fruit is also nutritionally and medicinally 
attractive for consumers. The Dragon fruit flesh is usually eaten raw or it is blended into juice while the remaining 
peel is discarded. In order to minimize this waste from Dragon fruit consumption, an idea of transforming the peel of 
Dragon fruit into edible pectin has been proposed. Pectin can be found in food products as gelling agent and it is 
used to maintain the quality of foods. Market demand for pectin is increasing annually and in order to meet the 
supply-demand, researchers are working towards obtaining pectin from available non-conventional sources. In this 
study, pectin was extracted from Dragon fruit peel by hot acid extraction. Optimum conditions (pH 3.5, 75 minutes of 
extraction) were considered to yield the highest amount of pectin. Distilled water was used as solvent and the acidic 
environment was achieved with dilute HCl. The extracted pectin was categorized as high methoxyl pectin based on 
estimated degree of esterification (52%). FTIR analysis detected pectin’s functional groups characteristics of 
carbohydrates, and the extracted pectin identity was confirmed by comparison with commercial pectin. Melting 
temperature (Tm) and melting enthalpy (ΔHm) of the Dragon fruit peel pectin analysed by DSC were 122.01 oC and 
385.40 mJ, respectively. The values were found to be higher than those of commercial pectin (107.11 oC and 77.81 
mJ, respectively). Ash content, water and oil holding capacity (WHC, OHC) and swelling capacity (SC) are among 
other characteristics of extracted pectin that were analysed. Analysis of variance (ANOVA) of these characteristics 
showed there were no significant difference (p> 0.05) when compared with commercial pectin. However, there was a 
significant difference (p< 0.05) in moisture content between the Dragon fruit peel pectin samples and commercial 
pectin. Pectin gel was formulated from extracted pectin and tested for its cohesiveness, gumminess and hardness. 
Result obtained indicates the texture of this pectin gel has no significant difference compared with pectin gel made 
from commercial pectin. Therefore, we concluded that the Dragon fruit peel has a great potential to be an alternative 
pectin substitute.  
 
Keywords: Pectin extraction, dragon fruit peel, characterization, commercial pectin. 
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Abstract 
Dietary supplements, including those containing botanical ingredients and botanical-derived 
compounds, have been marketed to consumers globally for many decades. However, the 
legislative framework for such products remains inconsistent across jurisdictions 
internationally. A  common  problem,  concerning these  nutraceutical product,  is  deficient  
information  and  lack  of  data  for  assessing  the  hazards  posed to  human  health. The main 
objective is  to  explore  the  use  of  in  silico  tools  in  a  risk  assessment  context  of  
nutraceutical  product,  to  relate  properties  of  the  molecular  structure  to  the  toxic  effect  
of  the chemical  substance,  by  using  principles  and  methods  of  computational  chemistry. 
Further consideration of the actual impact of adverse events arising from nutraceutical  food 
supplement usage will be helpful in guiding such issue as  potential for misidentification, and 
adulteration of botanical supplements by pharmacologically active substances. 
 




Nutraceutical can be define as a food or food product that reportedly provides a medical 
benefits, such as prevention and treatment of diseases. It is produced under GMP conditions 
and may range from isolated nutrients, dietary supplements and specific diets to genetically 
engineered foods, herbal products and process food (Mohammad et al., 2015). Example of 
nutraceutical products includes vitamins, mineral, herbal supplements, semi-purified substance 
from natural sources, plant extract,  functional food and beverages, probiotics and topical 
application for skin care (Labadi, S. 2017).  The therapeutics areas that is normally cover by 
nutraceuticals are anti-arthritic, cold and cough, prevention of certain cancer, diabetes, sleeping 
disorders, hypertension and osteoporosis (Pandey et al., 2010). Nutraceutical can be divided 
into three main segments which are natural products, dietary supplements and functional foods. 
Natural products and dietary supplements are segment with rapid growth due to high level of 
interest and demand by general public (Nutrition Business Journal, 2006).Such products are 
often comprehend as a more flattering as compared to pharmaceutical product as they are being 
seen as more natural and likely to incur minimum side effects (Teschke et al., 2013). Beside 
the availability of the nutraceutical products over the counter of supermarket, health food shop 
and pharmacies and lenient regulatory scrutiny before entering the market (Posadzki et al., 
2013).  
High cost incur by the modern disease treatment make consumer look for alternative or 
complementary beneficial product such as the appealing nutraceutical product. Only recently 
nutraceutical product been scientifically supported nutritional and medical evidence and 
become a  potentially effective alternatives (Dillard and German, 2000). A sturdy regulation 
and assessment need to be develop and implement to give impact on consumer and to 
standardised the nutraceutical compound. Besides, requirement of the execution of clinical 
studies, provide basis for health claims, commercial positioning and functional claims of  
nutraceutical products should be evidence based that supported by convincing scientific data 
from well design studies. Moreover, nutraceutical products often taken as “self-medication” 
without concern from the medical doctor regarding any diseases that may lead to uncertainty 
in the observed effects. Therefore, there should be special aspects that need to be consider 
instead of basic design study that is similar to that of pharmaceutical studies. (Gao et al., 2014).  
Considerably high number of cases that have been reported on the adverse effects of 
nutraceutical products that pose real risk to public (Rocha et al., 2016). The arising issue 
recently were the adulteration of nutraceutical products  with pharmaceutical substance and 
accidental replacement of botanicals with some other toxic plant or substance (Stegelmeier et 
al., 2015). Besides, compounds such as alkenylbenzenes estragole and methyleugenol that are 
naturally contain in some botanicals are found to be genotoxic and hepatocarcinogenic based 
on animal study done by  Scientific Committee on Food European Commission (SCF EC., 
2001). Reports on human studies associated with the severity of effect of the consumption of 
botanicals range that caused elevation in blood pressure, acute liver failure requiring liver 
transplantation, tumors of the urinary tract and even death (Fujita et al., (2007);  Nortier et al., 
(2009)). 
Unravel the kinetic profiles and rectifying the bioavailability of nutraceutical properties 
and nutritional compounds  posture some challenge especially in dealing with complex mixture 
derive from herbal plants. The main problem is to characterised the exact bioactive compound 
where regulating the bioactives intake is a challenge in term of variation in the plant 
composition. The variation further complicates the interpretation of different bioactives within 
botanical compound in nutraceutical that may exert either antagonistic or synergistic 
interaction(Schmitt and Farro, 2013).  
Animal  testing  has  been  used  to  provide  toxicological  information, but  in  addition  
to  the  ethical  consideration,  it  is  both  expensive  and  time consuming.  Alternatives  to  
animal  data,  i.e.,  non-testing  data  is  therefore desirable  and  is  highlighted to  promote 
alternative methods  for  the  assessment  of  hazards  of  substances. Non-testing  data  (or  
could be  expressed  as  non-animal-testing  data)  includes,  for  example,  in  vitro  data  but 
can  also  be  generated  using  in  silico  tools.  In  silico  means  within  computer,  and the  
term  ‘in  silico  tools’  is  collectively  used  to  refer  to  methods  as  structure reactivity  
relationships  (SARs),  quantitative  structure-activity  relationships (QSARs) (Puzyn et al., 
2010) and network pharmacology. 
Animal  studies  for  the  type  of  toxicological information  needed  are  both  expensive  
and  time  consuming,  and  to  that  an  ethical  aspect is  added.  Alternative  methods  to  
animal  testing  are  thereby  requested.  With the continuous maturation of computer 
technology, an  increased  use  of  in  silico  tools  for  non-testing  data  as  structure-activity 
relationships  (SARs),  quantitative  structure-activity  relationships  (QSARs),  and pathway 
and network analysis.   This lead to the rapid elucidation of the complex relationships between 
compounds and their various activity target (Rubio‑Perez et al., 2015).  The  main  objective  
is to  explore  the  use  of  in  silico  tools  in  a  risk  assessment  context  of  nutraceutical 
products.  In particular,  try  to  relate  properties  of  the  molecular  structure  to  the  toxic  
effect  of  the chemical  substance,  by  using  principles  and  methods  of  computational  
chemistry. 
 
2. Discussion  
2.1 Risk assessment and regulation 
The assessment criteria for the nutraceutical products are generally similar between 
some country such as Australia, USA and Europe (EU). Particularly, information related to 
requirement of basic information of the botanical substance and description of the botanical 
substance and description of manufacturing process (Low et al., 2017). However, jurisdiction 
regarding the specific toxicology data requirement, clinical trial data and adverse reaction 
report of nutraceutical product are mostly diversify. For example in term of requirement on 
specific toxicological studies, European Food Safety Authority (EFSA) is comparatively brief 
as compared to Therapeutic Goods Administration, Australia (TGA) and U.S. Food and Drug 
Administration (FDA) whose describe the necessary toxicity studies in more detail (Low et 
al.,2017).  FDA even take an initiative to come out with a “Safety Testing Recommendation 
Matrix” that has been a good references for business operator as it recommend a different 
combination of toxicology data based on the historical used of the ingredients to determine the 
possible toxicity of their products. This matrix help the business operator in a way of reducing 
the cost and the hassle of conducting the toxicity study (FDA 2016).  
Data on clinical trials are required by TGA guideline for risk assessment as TGA 
regulates the nutraceutical product as complementary medicine rather that food supplement 
(TGA 2016).  EFSA on the other hand does not acquire such data and the fact that it is not 
obligatory either for FDA to provide the clinical trials data but they required at least to have a 
tolerability studies on adsorption, distribution, metabolism and excretion (ADME) studies to 
determine the safety margin for one products (FDA 2016).    
The development of extraction technologies, pose a new risk related to botanical 
through the dynamic of economically motivated fraud. Moreover, there are some aspects that 
not been considered in the guidance documents for risk and safety assessment of nutraceutical 
products. Despite the uncertainty of the authentication and differences in regulation, the global 
nutraceutical market has been valued at USD 109.8 billion and expected to grows to an 
expected value of USD 180 billion by 2020 (Persistence Market Research 2015). Therefore, 
the current issues should set the direction in the nutraceutical field that highlight the evidence-
based nutraceutical approach can make important contribution to public health.   
 
2.2 SAR and QSAR 
SAR analysis is the identification of chemical properties or specific fragments of the 
molecular structure involved in an observed or measured effect. A QSAR model approximates 
the relationship between the molecular structure and a biological activity in a quantitative 
manner (Eriksson, et al., 2003). The QSAR model can be used to determine SAR. Prior to a 
quantitative correlation, the biological or toxic activity as well as the chemical and structural 
properties are defined with numerical values. The outcome of biochemical and toxic effects of 
particular substances were measured in in vitro assays.  QSAR modelling begins with a set of 
chemical structures that are assumed to act by the same  mechanism of action, and then follows 
a stepwise process as the general pathway illustrated in Figure 1. 
In order to enhance the regulatory acceptability and use of QSAR, the organisation for 
economic co-operation and development (OECD) outlined principles for QSAR validation 
(OECD, 2007). According to these principles, a QSAR model should be associated with 1) a 
defined endpoint, 2) an unambiguous algorithm, 3) a defined domain of applicability, 4) 
appropriate measures of goodness-of-fit, robustness and predictivity, and if possible, 5) a 
mechanistic interpretation. The aim of this principle is to ensure that selection of the chemical 
descriptors is well considered in relation to the endpoint of the investigation, and that any 
association found between the chemical descriptors and the endpoint is documented (OECD, 
2007). 
 
2.3 Pathway and network analysis 
In recent years, with an increasingly in-depth understanding of the structure and 
function of  compounds, a series of new technologies and methods have been applied to the 
development of medicinal plants (Yi et al., 2016). If we can establish a quick and convenient 
pathway by which to first accurately predict a large number of chemical compounds and then, 
based on these results, perform in vivo and in vitro pharmacological experiments for 
verification, this procedure will significantly improve the efficiency of evaluating the chemical 
activities of nutraceutical product. 
The continuous maturation of computer technology, the in silico approach of utilizing 
a computer platform to calculate the combinations of simulated compounds and targets has 
become increasingly accurate. In addition, the development of network pharmacology 
technologies has enabled the rapid elucidation of the complex relationships between 
compounds and their various activity targets (Rubio-Perez et al., 2015). 
Its complexity is not only reflected in the composition of the chemical constituents but 
also embodied in the network of relationships between the prescription and the human body 
and the exertion of pharmacological effects through multiple channels, multiple targets and the 
overall regulatory mechanism (Zhang et al., 2016). 
Considering the medicinal plant as the object and virtual computational screening as 
the central methodology within nutraceutical informatics, and using network pharmacology as 
the technical means, we have employed a set of effective and accurate methods to reveal the 
pharmacological basis of the effects of medicinal plant materials and predict the potential 
bioactivity of their compounds. The approach proceeds from the selection of the plant active 
compounds to virtual screening and evaluation of the targets, related signalling pathways and 
disease networks (Yi et al., 2018). Techniques from virtual computational screening and 
network pharmacology are used to construct a complete technical routine for this methodology. 
The first step is to confirm the research significance of the plants. These medicinal plants can 
be organized into three categories: (1) common herbs with a more complex mechanism than 
that of other herbs; (2) herbs with a long history of traditional usage but fewer studies on their 
phytochemistry and haemacology; and (3) herbs with a history of traditional usage but now 
with a new utilization (Yi et al., 2018).  
The second step is the organization and collection of the natural products to construct 
the natural products database. The third step is the pre-treatment of these compounds, including 
drug-like analysis, ADME/T (absorption, distribution, metabolism, excretion and toxicity) 
prediction and the exclusion of false-positive compounds. The fourth step is the core technique 
of this methodology, the in silico virtual screening. This step were design by combining three 
different theoretical bases: the first is virtual target fishing based on pharmacophore theory; the 
second is dual validation based on small molecule shape similarity theory; and the third is 
compound-target analysis based on docking. The fifth step is the analysis of the set of targets 
identified. By utilizing the technical methods of network pharmacology and different protein 
information databases and websites, we can analyse the relationships of signalling pathways, 
pathological pathways and related diseases with potential targets. Finally, the network of 
relationships was constructed among medicinal plants, natural compounds, biological targets, 
signalling pathways, and diseases. We thereby elucidate the mechanistic basis of the effects of 
the natural compounds in medicinal plants  and predict their potential pharmacological 
activities (Yi et al., 2018). 
 
3. Conclusion  
The alternative  strategies  for  the  assessment of  hazards  to  complement in vitro and  in  vivo  
studies for nutraceutical products has been explore.  The  potential  of  using  different  in  silico  
methods  for this  purpose  has  been  investigated  and  QSAR  models  have  been  studied. 
Information  contained  in  two  diverse  datasets  of  nutraceutical product  was searched  with  
SAR  and  QSAR  methods. Wide-ranging complete technical route that utilizes a series of in 
silico approaches to reveal the pharmacological basis of the effects of medicinal plants were 
proposed. This in silico methodology can resolve the status of medicinal plants that are difficult 
to study on a practical level and can predict and clarify the mechanisms of the active ingredients 
in nutraceutical product. Through more practical researches and development examples to 
upgrade the entire process of in silico methodology, we believe that in the future, this 
methodological process will enable the discovery of new active compound more efficiently, 
accurately and quickly. This methodology will be more widely usable in future work on 
revealing and predicting the basis of nutraceutical materials. 
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